Matches in SemOpenAlex for { <https://semopenalex.org/work/W3154155032> ?p ?o ?g. }
- W3154155032 abstract "Abstract Drug repositioning refers to new uses for existing drugs outside the scope of the original medical indications. This approach fastens the process of drug development allowing finding effective drugs with reduced side effects and lower costs. Colorectal cancer (CRC) is often diagnosed at advanced stages, when the probability of chemotherapy resistance is higher. Triple negative breast cancer (TNBC) is the most aggressive type of breast cancer, highly metastatic and difficult to treat. For both tumor types, available treatments are generally associated to severe side effects. In our work, we explored the effect of combining metformin and propranolol, two repositioned drugs, in both tumor types. We demonstrate that treatment affects viability, epithelial-mesenchymal transition and migratory potential of CRC cells as we described before for TNBC. We show that combined treatment affects different steps leading to metastasis in TNBC. Moreover, combined treatment is also effective preventing the development of 5-FU resistant CRC. Our data suggest that combination of metformin and propranolol could be useful as a putative adjuvant treatment for both TNBC and CRC and an alternative for chemo-resistant CRC, providing a low-cost alternative therapy without associated toxicity." @default.
- W3154155032 created "2021-04-26" @default.
- W3154155032 creator A5005300802 @default.
- W3154155032 creator A5006016730 @default.
- W3154155032 creator A5018882770 @default.
- W3154155032 creator A5026376296 @default.
- W3154155032 creator A5029890948 @default.
- W3154155032 creator A5037772624 @default.
- W3154155032 creator A5052667109 @default.
- W3154155032 creator A5067548327 @default.
- W3154155032 creator A5083172029 @default.
- W3154155032 creator A5084745027 @default.
- W3154155032 creator A5090268707 @default.
- W3154155032 date "2021-04-14" @default.
- W3154155032 modified "2023-10-15" @default.
- W3154155032 title "Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment" @default.
- W3154155032 cites W1256125786 @default.
- W3154155032 cites W1501141911 @default.
- W3154155032 cites W1586324952 @default.
- W3154155032 cites W1976631815 @default.
- W3154155032 cites W2000633272 @default.
- W3154155032 cites W2010238923 @default.
- W3154155032 cites W2010366112 @default.
- W3154155032 cites W2013006388 @default.
- W3154155032 cites W2026967508 @default.
- W3154155032 cites W2027988626 @default.
- W3154155032 cites W2060224273 @default.
- W3154155032 cites W2067571641 @default.
- W3154155032 cites W2067815489 @default.
- W3154155032 cites W2077666442 @default.
- W3154155032 cites W2085210523 @default.
- W3154155032 cites W2085331940 @default.
- W3154155032 cites W2095915493 @default.
- W3154155032 cites W2098464561 @default.
- W3154155032 cites W2104504474 @default.
- W3154155032 cites W2115860567 @default.
- W3154155032 cites W2118605519 @default.
- W3154155032 cites W2128447158 @default.
- W3154155032 cites W2129596231 @default.
- W3154155032 cites W2131719921 @default.
- W3154155032 cites W2133761735 @default.
- W3154155032 cites W2136472841 @default.
- W3154155032 cites W2139731996 @default.
- W3154155032 cites W2141589190 @default.
- W3154155032 cites W2144495943 @default.
- W3154155032 cites W2146780639 @default.
- W3154155032 cites W2147589302 @default.
- W3154155032 cites W2156123588 @default.
- W3154155032 cites W2161882832 @default.
- W3154155032 cites W2163692077 @default.
- W3154155032 cites W2166300010 @default.
- W3154155032 cites W2167504781 @default.
- W3154155032 cites W2171998898 @default.
- W3154155032 cites W2312655978 @default.
- W3154155032 cites W2323045903 @default.
- W3154155032 cites W2336052913 @default.
- W3154155032 cites W2336831152 @default.
- W3154155032 cites W2349230331 @default.
- W3154155032 cites W2402636472 @default.
- W3154155032 cites W2530867754 @default.
- W3154155032 cites W2531169769 @default.
- W3154155032 cites W2546693363 @default.
- W3154155032 cites W2559365457 @default.
- W3154155032 cites W2580010787 @default.
- W3154155032 cites W2770313364 @default.
- W3154155032 cites W2770576752 @default.
- W3154155032 cites W2788374915 @default.
- W3154155032 cites W2804888201 @default.
- W3154155032 cites W2805723250 @default.
- W3154155032 cites W2807188419 @default.
- W3154155032 cites W2884436397 @default.
- W3154155032 cites W2889646458 @default.
- W3154155032 cites W2891001788 @default.
- W3154155032 cites W2891141728 @default.
- W3154155032 cites W2899450027 @default.
- W3154155032 cites W2902166610 @default.
- W3154155032 cites W2904553013 @default.
- W3154155032 cites W2909619340 @default.
- W3154155032 cites W2943966322 @default.
- W3154155032 cites W2953778893 @default.
- W3154155032 cites W2955745348 @default.
- W3154155032 cites W2965236776 @default.
- W3154155032 cites W2968820602 @default.
- W3154155032 cites W2989593825 @default.
- W3154155032 cites W2995188607 @default.
- W3154155032 cites W3015105383 @default.
- W3154155032 cites W3093085805 @default.
- W3154155032 cites W4211168195 @default.
- W3154155032 doi "https://doi.org/10.1038/s41598-021-87525-z" @default.
- W3154155032 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8047046" @default.
- W3154155032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33854147" @default.
- W3154155032 hasPublicationYear "2021" @default.
- W3154155032 type Work @default.
- W3154155032 sameAs 3154155032 @default.
- W3154155032 citedByCount "12" @default.
- W3154155032 countsByYear W31541550322021 @default.
- W3154155032 countsByYear W31541550322022 @default.
- W3154155032 countsByYear W31541550322023 @default.
- W3154155032 crossrefType "journal-article" @default.
- W3154155032 hasAuthorship W3154155032A5005300802 @default.